Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,096
Total Claims
$937K
Drug Cost
537
Beneficiaries
$1,745
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-91%
Opioid rate vs peers
0.8% vs 9.2% avg
+143%
Cost per patient vs peers
$1,745 vs $719 avg
+75%
Brand preference vs peers
11.7% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.8%
Opioid Rate
89
Opioid Claims
$585
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,288 claims · $738K
Generic: 9,754 claims · $195K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 149 | $115K |
| Dulaglutide | 81 | $95K |
| Semaglutide | 69 | $80K |
| Tirzepatide | 60 | $78K |
| Apixaban | 57 | $59K |
| Sitagliptin Phosphate | 50 | $40K |
| Fluticasone/Umeclidin/Vilanter | 31 | $26K |
| Rivaroxaban | 35 | $21K |
| Sitagliptin Phos/Metformin Hcl | 16 | $17K |
| Empagliflozin | 15 | $14K |
| Insulin Glargine/Lixisenatide | 19 | $14K |
| Pitavastatin Calcium | 34 | $12K |
| Insulin Aspart Prot/Insuln Asp | 11 | $11K |
| Mirabegron | 13 | $9,042 |
| Umeclidinium Brm/Vilanterol Tr | 14 | $8,921 |
Prescribing Profile
Patient Profile
71
Avg Age
53%
Female
1.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data